Fig. 5
Analysis of gender difference risk signals in omalizumab. (A) Reporting odds ratios (ROR) with 95% CI for all positive gender-related ADEs. (B) Gender difference risk signal volcano. plot for omalizumab.
Fig. 5 | Scientific Reports
Analysis of gender difference risk signals in omalizumab. (A) Reporting odds ratios (ROR) with 95% CI for all positive gender-related ADEs. (B) Gender difference risk signal volcano. plot for omalizumab.
